Conference Proceedings

APASL, 2021

• The impact of expanding antiviral treatment criteria at a population level in the Republic of Korea: A modeling analysis
• Simplified test & treat protocols to eliminate HCV & HBV in Uzbekistan

EASL, 2021

• The global non-alcoholic fatty liver disease (NAFLD) preparedness index: Are countries ready to tackle the challenge?
• Modeling HCV elimination recovery following the COVID-19 pandemic in the United States: Pathways to regain progress
• Simplified test & treat protocols for population level screening and elimination of hepatitis B and hepatitis C in Uzbekistan
• Modeling disease burden of nonalcoholic fatty liver disease (NAFLD) in Japan

Canadian Liver Meeting, 2020

• NAFLD Disease Burden — Canada, 2019-2030

EASL, 2020

• Global prevalence of hepatitis C virus in women of childbearing age in 2019: A modeling study
• Catalytic funding for viral hepatitis elimination program in Uzbekistan
• Global timing of hepatitis C virus elimination in high-income countries: an updated analysis
• Anticipated timing of elimination of hepatitis C virus in Canada’s four most populous provinces
• Do countries have the right policies to eliminate viral hepatitis B and C: a secondary analysis of the Lancet GastroHep Viral Hepatitis Commission
• The Hep-CORE Policy Score: A European hepatitis C national policy implementation ranking

APPSP

• Eliminating hepatitis C in Portugal: Treatment and diagnosis requirements for two timelines

EASL, 2019

• Global timing of hepatitis C virus elimination: estimating the year countries will achieve the World Health Organization elimination targets
• Achieving accelerated elimination of hepatitis C virus infection by 2025: a case study in France
• The Consensus Hepatitis C Cascade of Care: Methodology and initial findings from three countries
• Screening strategies for hepatitis C virus elimination in Italy
• Modeling NAFLD-related disease progression among the PITER SVR12 cohort

Paris NASH Meeting, 2018

• The value proposition of NASH therapy on the burden of disease related to obesity

Global Hepatitis Summit

• Elimination of Hepatitis C in Brazil is Cost-Saving – courtesy of Ministry of Health, Brasilia, Brazil
• Should changing epidemiology change HAV vaccination policy?
• Global Cascade of Care for HBV and HCV
• Estimates and projection of disease burden and economic analysis for hepatitis B in Viet Nam
  
• Estimates and projection of disease burden and economic analysis for hepatitis C in Viet Nam
  

EASL, 2018

• Achieving World Health Organization Targets for Hepatitis B by 2030: Results from 17 WHO AFRO Countries
• Achieving World Health Organization Targets for Hepatitis B in Infants and 5-year olds by 2030: Results from 17 WHO AFRO Countries
• Forecasting liver disease burden based on a real life cohort of linked to care patients in Italy. Does the “hidden portion of the iceberg” matter to reach the WHO HCV elimination goals in high HCV prevalent countries?
• Hepatitis C infection in the Pan American Health Organization Region: The current burden of disease and a road map for achieving the World Health Organization Global Health Sector Strategy Goals
• Hepatitis C infection in the Pan American Health Organization Region: The current burden of disease and a road map for achieving the World Health Organization Global Health Sector Strategy Goals
• Impact of the Hepatitis B Vaccine Birth-Dose on Perinatal Incidence between 2017-2050: Results from 17 WHO AFRO Countries
• Micro-Elimination of Chronic Hepatitis C in Switzerland: Modelling the Swiss Hepatitis Strategy Goals in Urban and Rural Regions
• Quantifying the Impact of Achieving the World Health Organization Global Health Sector Strategy Goals for Hepatitis C in the AFRO Region
• Quantifying the impact of achieving the World Health Organization global health sector strategy goals for hepatitis C in the EURO region
• The current and future disease burden of hepatitis B virus in the general population and among five year-olds in the Eastern Mediterranean Region
• The Global Prevalence of HBsAg by Age in 2016 and the Case for Universal Treatment in Low and Middle Income Countries

APASL, 2018

• Achieving the World Health Organization Global Health Sector Strategies for Hepatitis C in the WHO Western
  Pacific Region: A Modelling Study
• Disease Burden of Hepatitis B in the Kyrgyz Republic: A Focus on Prevention
• Eliminating Hepatitis C Virus (HCV) in Indonesia
• Hepatitis C Infection in the Eastern Mediterranean Region: The Current Burden of Disease and a Road Map for Achieving the WHO Global Health Sector Strategy Targets
• Quantifying the Impact of Achieving the World Health Organization Global Health Sector Strategy Targets for Hepatitis C in the South East Asia Region
• The Disease Burden of Hepatitis B in Republic of Uzbekistan: Strategies Providing Hope for the Future